Cannon GW - Search Results

1

Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis.

Mikuls TR, LeVan TD, Sayles H, Yu F, Caplan L, Cannon GW, Kerr GS, Reimold AM, Johnson DS, Thiele GM. Mikuls TR, et al. Among authors: cannon gw. J Rheumatol. 2011 Dec;38(12):2509-16. doi: 10.3899/jrheum.110378. Epub 2011 Sep 15. J Rheumatol. 2011. PMID: 21921097

2

Prospective two-year followup of recombinant interferon-gamma in rheumatoid arthritis.

Cannon GW, Emkey RD, Denes A, Cohen SA, Saway PA, Wolfe F, Jaffer AM, Weaver AL, Cogen L, Gulinello J, et al. Cannon GW, et al. J Rheumatol. 1990 Mar;17(3):304-10. J Rheumatol. 1990. PMID: 2110252

3

Inhibition of the passive transfer of adjuvant induced arthritis by gold sodium thiomalate.

Cannon GW, McCall S. Cannon GW, et al. J Rheumatol. 1990 Apr;17(4):436-8. J Rheumatol. 1990. PMID: 2112197

4

In vivo administration of interferon-gamma to patients with rheumatoid arthritis decreases numbers of circulating B cells.

Pincus SH, Cannon GW, Ward JR. Pincus SH, et al. Among authors: cannon gw. J Rheumatol. 1990 Jun;17(6):751-7. J Rheumatol. 1990. PMID: 2117659

5

Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate.

Cannon GW, Marble DA, Griffiths MM, Cole BC, McCall S, Schulman SF, Strand V. Cannon GW, et al. J Rheumatol. 1995 Feb;22(2):207-13. J Rheumatol. 1995. PMID: 7537827

6

Induction of arthritis in DA rats by incomplete Freund's adjuvant.

Cannon GW, Woods ML, Clayton F, Griffiths MM. Cannon GW, et al. J Rheumatol. 1993 Jan;20(1):7-11. J Rheumatol. 1993. PMID: 8441169

7

Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.

Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V. Kremer J, et al. Among authors: cannon gw. J Rheumatol. 2004 Aug;31(8):1521-31. J Rheumatol. 2004. PMID: 15290730 Clinical Trial.

8

Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.

Cannon GW, Holden WL, Juhaeri J, Dai W, Scarazzini L, Stang P. Cannon GW, et al. J Rheumatol. 2004 Oct;31(10):1906-11. J Rheumatol. 2004. PMID: 15468352

9

Benefit/risk of leflunomide in rheumatoid arthritis.

Kremer JM, Cannon GW. Kremer JM, et al. Among authors: cannon gw. Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S95-100. Clin Exp Rheumatol. 2004. PMID: 15552521 Review.

10

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.

Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, Tugwell P, Crawford B; Leflunomide Rheumatoid Arthritis Investigators Groups. Strand V, et al. Among authors: cannon gw. J Rheumatol. 2005 Apr;32(4):590-601. J Rheumatol. 2005. PMID: 15801012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters